INS and gestational diabetes: Additionally, the overexpression of inflammatory mediators, alongside a remarkable rise in reactive oxygen species (ROS), could potentially cause further metabolic changes leading to the inhibition of the insulin secretion pathway, and consequently lead to reduced beta-cell insulin secretion and GDM.